These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators. J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454 [Abstract] [Full Text] [Related]
3. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A. Pharmacotherapy; 2007 May 27; 27(5):691-6. PubMed ID: 17461704 [Abstract] [Full Text] [Related]
4. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators. Am Heart J; 2006 Nov 27; 152(5):967-73. PubMed ID: 17070169 [Abstract] [Full Text] [Related]
5. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients. Blich M, Gross B. Int J Cardiol; 2004 Jul 27; 96(1):89-95. PubMed ID: 15203266 [Abstract] [Full Text] [Related]
6. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable. Coleman CI, Straznitskas AD, Sobieraj DM, Kluger J, Anglade MW. Am J Cardiol; 2012 Apr 01; 109(7):1020-5. PubMed ID: 22221944 [Abstract] [Full Text] [Related]
8. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S, Trappolini M, Chillotti FM. Minerva Cardioangiol; 2001 Feb 01; 49(1):1-13. PubMed ID: 11279381 [Abstract] [Full Text] [Related]
10. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Roijer A, Eskilsson J, Olsson B. Eur Heart J; 2000 May 01; 21(10):837-47. PubMed ID: 10781356 [Abstract] [Full Text] [Related]
13. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy]. J Cardiol; 1998 Apr 01; 31(4):227-38. PubMed ID: 9594372 [Abstract] [Full Text] [Related]
17. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237 [Abstract] [Full Text] [Related]